comparemela.com

Latest Breaking News On - Corbus pharmaceuticals stock down - Page 1 : comparemela.com

Corbus Pharmaceuticals (NASDAQ:CRBP) Upgraded by StockNews com to Hold

StockNews.com upgraded shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) from a sell rating to a hold rating in a research note published on Saturday. Separately, Oppenheimer raised their price target on Corbus Pharmaceuticals from $20.00 to $51.00 and gave the stock an outperform rating in a research report on Monday, January 29th. Get Our […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.